로딩 중…
StockDiggingStockDigging

MEKICS CO., Ltd

058110· KOSDAQ
₩2,070-0.72%
2026-06-19

Price Chart

MEKICS CO., Ltd-13.21%

Financials

Investment Metrics(as of 2026-06-19)

MetricValue
Size
Market Cap33.22B KRW
Revenue12.26B KRW
Net Income454.7M KRW
Total Assets57.31B KRW
Net Assets37.21B KRW
Employees106
Value
P/E73.07x
P/B0.89x
P/S2.71x
EV/EBITDA26.27x
FCF Yield-7.71%
Profitability
ROE1.22%
ROA0.79%
Op. Margin13.81%
Revenue Growth33.35%
Financial Health
Debt Ratio154.03%
Total Debt15.49B KRW
FCF-2.56B KRW
Cash4.24B KRW
Current Ratio1.27x
Net Debt/EBITDA6.65x
Dividend
Div. Yield1.41%
Performance
1Y Return-13.21%
1M Return-15.68%
From 52W High-48.25%
1Y MDD-50.30%
Trading
Volume38,516 shares
Foreign Own.5.50%
Per Share
EPS-54 KRW
BPS2,396 KRW

Company Info

CEO 김종철
Employees 106
Founded 1998
HQ 경기도 파주시, KR

Mecics, established in 1998 and listed on KOSDAQ in 2015, designs, manufactures, and sells medical devices such as artificial respirators, respiratory therapy devices, and patient monitoring devices for emergency rooms and intensive care units. The company developed Korea's first artificial respirator, securing international competitiveness. It leads the global market with world-class high-flow respiratory therapy technology and is expanding sales following US FDA approval and Japan PMDA registration. Mecics was established in 1998 and is headquartered in Paju, Gyeonggi-do.